Given the essential roles that PERK activation and eIF2B regulation play in β-cells, therapeutic targets that may lead to an abatement of stress, i.e., key factors in these stress pathways or rescue of function of those same factors, are potential and exciting approaches to restore β-cell health in diabetes. The gene discussed is EIF2B4; the disease is diabetes mellitus.